pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-433 |
Genomic Coordinates | chr14: 100881886 - 100881978 |
Synonyms | MIRN433, hsa-mir-433, miRNA433, MIR433 |
Description | Homo sapiens miR-433 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-433-3p | ||||||||||||
Sequence | 64| AUCAUGAUGGGCUCCUCGGUGU |85 | ||||||||||||
Evidence | Experimental | ||||||||||||
Experiments | Cloned | DRVs in miRNA |
|
||||||||||
SNPs in miRNA |
|
||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | CHD9 | ||||||||||||||||||||
Synonyms | AD013, CHD-9, CReMM, KISH2, PRIC320 | ||||||||||||||||||||
Description | chromodomain helicase DNA binding protein 9 | ||||||||||||||||||||
Transcript | NM_025134 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on CHD9 | |||||||||||||||||||||
3'UTR of CHD9 (miRNA target sites are highlighted) |
>CHD9|NM_025134|3'UTR 1 TTCCCAGACTCTGCACTTAAAATATGAACTGATTTTGGATTTTTTCTTTAATAATTAATTGTAAATACCCCAGTGTTGAG 81 TGCATCAATAACTTACTGACCGAACATTTCAGTTATTTGTTTAGAAGTGCAAACTGCTTTCAGAGACTTTTTGCATGTAA 161 TATTTCTTAAGATTCATAAGTTTCTGAACTCGTATGTACTATCAAATACATAAAGGTGTAAAATTACAACAAAAGGCATT 241 ATAATTTTGTTGGGGGTTAATTTTATGAAAATTATGCTCAATAAGAGTTGTATATTTAATATATTTGCAGTGAACACAGA 321 ATACTTTATGCATATTACTGATTTAATTTGAATATAGTTTTACAGCCTCCTTGACACCTATAATTTACAGATCAAAACTC 401 AGCAATAATTTGGGCAGCTAATGAATGTCATGAAAGCTGTAGAATCTACATCACCATCCATTGCTTTAATTACATGAAAA 481 TGCTCTAGTGTTGTGATGCACTGCTGATGTTTCCAATTCAGGTACAAGTATGTTTTAAAGAAGAAATAAGTTTCCCAATC 561 AGCCAATTTAACTGGCTACCTGTTACCTCAGCTGAGTTAGTTTAGGAAGTTTACATTCGTTTCTAATTCTATACTTGTTT 641 TCAGGGGTTTTTTAAACACATCCTATATATCATGTCAATCTGGCAAGAAATATGACTTGCTTTTTGCTGAGCTTAATTCA 721 GATATCAGTAAAATTAAGTCATAAAATAATCATGTGTCATGTGACTTTGGCACCCTATAGACATACTTAGTTTTAACTTT 801 TCAAAGTTTGGCCTCCTATTAGAAATAATCATGTCTCAGATGAGTAATGTCTGTTTCCAGGGTTCAGAAAAGGCAAACTC 881 ATGAAATGCCACTGAAAAGAACTTTCAACACAGCATACTTCATGTAAAAGAAATTGTTTGTTTGCTTTCTTTGTGTAGAT 961 TTCTATTTGTGTTTTATGTCATGGAAATATTCCAGAATTAACAGATAATAGTGGTAAAGTAATATGCAGATAGTCTAAAT 1041 TCATTTTGAGTTTCTAGGTGTAAGCAGACTAAATGTTGCCCAGAATCAGTGTTGGGTTATCAGTTTATATTAAATATACT 1121 GAGTTGCCCGTTTTGAAAATGCACTTTGAATAATCTCAAAAAGATGTACAAGTTATACCTGTAAACCACAAAAGTGAAGC 1201 CTGAGGCTTCTGTTCAATTTCATAGACTCCTTTACCATGTAAAATTTGTCTGATATTTGATTTGTGATACAATTTCTCCT 1281 GCTAAAGCTGCTATTATTCTGACAAGGTAGAGGTCCAGGTTCACCTTTATATATATTTAAAACAATTAGTACTGAATTGG 1361 ACATAAAAATATTGACATTCTAAGGAGAGATATATGTTAGCATTTTTCTGGTACTCAAATAAGTTAGTAGTAAAGTCTGC 1441 AAGGGCATAAATTTAGGGGGAAAAAGTGTCCCAGTTCTCTCCTACAGAAAAAATACTTTCAGTATGTTTTGATAAAACTG 1521 TTGCTTTGTCATGAGTTAGTCAATTGTATCAGGTTTTCCAAGACCTTTACCAGTAAATTATGTTTCTGTATGTAAAATAA 1601 CCCCTTATTAGAGAGACAGTGTTATATGTATTTACAAAATTATATAAGTTCCATTGGGATTGTATTGATTTTGTATTTTC 1681 CCAAAATAGTACTTTGAATTGATAGTCCTTTATGCAATGTCTTAGCAATAGTCTCTATAATGCCCATCCAGGAGAAGTGG 1761 GTAGTAATTCTTCATCATGAAAATGATATATTACATATTTAGTATCTTCCCTTTGCAGTATTGCACTTTTGTTTAACTAG 1841 AATACACCTATGAGATAGCCAAAGTTTCAAACACAGTTATCTTAGTTTACCGGTGGAGTATTTCAACACCAACCACATTT 1921 CCCTTCCTCCCTCTAATTCTACCCACATGATCTTTATTCCTTCCTTTCGCCAATTAAAAAAAAAAAAAAGGAAAAAAAAT 2001 CTGTAGATCTTGTCACTAAAATCTAATTTATATCAAATTTATGAGAGAAAGTATTTTCCTAATTATGGTCAAATAAATTT 2081 GGTTAACATCCTAGTGATTCTCTTTCTATATAATAAGGCAATTACAGTTTTCAAAGCATTAAGTCTAACATAACTTTAAA 2161 CATTCTCTTAGGTTTCAAGACACTTCTATTTAATATTCATTGGGGAAAAGTTGTCCAGCTATCAGCTAAGAAAACACATG 2241 CAAATATGGTTGTGTAAAGTTAAGGGTTATAAGGAAAAAAAAATCAGTAGAATTACATAATACTAAAGTTGCAGTTGAAA 2321 GAATATCCAAGTATGTGTTGGTAGTTACTAAAAGAATTATAGCTGTTATTGCCTTGTATTTATAGCCCTTGTTTCAGGTT 2401 TTATGATTCAAGTCTTAGTCCAATCTTTCTTTTGGACATTTGCAATATTTACCAGTTGTGTTTTGTGTAGTCTGAATTTG 2481 CTTTCTGTAGTTGAGCAAACGTCTTAAAAAGTCATTTGTAATTTATTAAATTACTTTCTATGATGTTCTATAGAGCAAAT 2561 GGAAGTTTAATTATTTTTTATTAAACATATTCTTTGACTACCCATGAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Hela |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1048187. RNA binding protein: AGO2. Condition:Hela_AGO2_CLIP_control
... - Xue Y; Ouyang K; Huang J; Zhou Y; Ouyang H; et al., 2013, Cell. |
Article |
- Xue Y; Ouyang K; Huang J; Zhou Y; Ouyang H; et al. - Cell, 2013
The induction of pluripotency or trans-differentiation of one cell type to another can be accomplished with cell-lineage-specific transcription factors. Here, we report that repression of a single RNA binding polypyrimidine-tract-binding (PTB) protein, which occurs during normal brain development via the action of miR-124, is sufficient to induce trans-differentiation of fibroblasts into functional neurons. Besides its traditional role in regulated splicing, we show that PTB has a previously undocumented function in the regulation of microRNA functions, suppressing or enhancing microRNA targeting by competitive binding on target mRNA or altering local RNA secondary structure. A key event during neuronal induction is the relief of PTB-mediated blockage of microRNA action on multiple components of the REST complex, thereby derepressing a large array of neuronal genes, including miR-124 and multiple neuronal-specific transcription factors, in nonneuronal cells. This converts a negative feedback loop to a positive one to elicit cellular reprogramming to the neuronal lineage.
LinkOut: [PMID: 23313552]
|
CLIP-seq Support 1 for dataset GSM1048187 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | Hela / Hela_AGO2_CLIP_control |
Location of target site | ENST00000566029.1 | 3UTR | AUUUACAGAUCAAAACUCAGCAAUAAUUUGGGCAGCUAAUGAAUGUCAUGAAAGCUGUAGAAUCUACAUCA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23313552 / GSE42701 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
75 hsa-miR-433-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT001201 | GRB2 | growth factor receptor bound protein 2 | 3 | 1 | ||||||||
MIRT001741 | FGF20 | fibroblast growth factor 20 | 3 | 1 | ||||||||
MIRT007225 | RUNX2 | runt related transcription factor 2 | 1 | 1 | ||||||||
MIRT007361 | CFTR | cystic fibrosis transmembrane conductance regulator | 1 | 1 | ||||||||
MIRT016630 | HDAC6 | histone deacetylase 6 | 1 | 1 | ||||||||
MIRT053561 | KRAS | KRAS proto-oncogene, GTPase | 3 | 1 | ||||||||
MIRT082022 | COX6B1 | cytochrome c oxidase subunit 6B1 | 2 | 4 | ||||||||
MIRT086929 | CREB1 | cAMP responsive element binding protein 1 | 3 | 1 | ||||||||
MIRT096407 | C5ORF22 | chromosome 5 open reading frame 22 | 2 | 2 | ||||||||
MIRT135569 | SPRYD4 | SPRY domain containing 4 | 2 | 2 | ||||||||
MIRT143520 | CHD9 | chromodomain helicase DNA binding protein 9 | 2 | 2 | ||||||||
MIRT167706 | HIVEP1 | human immunodeficiency virus type I enhancer binding protein 1 | 2 | 8 | ||||||||
MIRT207568 | STARD7 | StAR related lipid transfer domain containing 7 | 2 | 4 | ||||||||
MIRT252052 | WDR45B | WD repeat domain 45B | 2 | 2 | ||||||||
MIRT327787 | YIPF6 | Yip1 domain family member 6 | 2 | 2 | ||||||||
MIRT406144 | SERBP1 | SERPINE1 mRNA binding protein 1 | 2 | 2 | ||||||||
MIRT437355 | GBP2 | guanylate binding protein 2 | 3 | 1 | ||||||||
MIRT438242 | TYMS | thymidylate synthetase | 3 | 1 | ||||||||
MIRT438553 | AZIN1 | antizyme inhibitor 1 | 4 | 1 | ||||||||
MIRT444186 | SCAMP1 | secretory carrier membrane protein 1 | 2 | 2 | ||||||||
MIRT477737 | EDN1 | endothelin 1 | 2 | 2 | ||||||||
MIRT483052 | SMU1 | DNA replication regulator and spliceosomal factor | 2 | 2 | ||||||||
MIRT485778 | ATXN1 | ataxin 1 | 2 | 2 | ||||||||
MIRT498142 | FKBP1C | FK506 binding protein 1C | 2 | 4 | ||||||||
MIRT499050 | SSC5D | scavenger receptor cysteine rich family member with 5 domains | 2 | 8 | ||||||||
MIRT501959 | MAPK8 | mitogen-activated protein kinase 8 | 2 | 2 | ||||||||
MIRT503281 | TMEM229B | transmembrane protein 229B | 2 | 4 | ||||||||
MIRT503597 | ZNF780A | zinc finger protein 780A | 2 | 2 | ||||||||
MIRT504577 | UGT2B4 | UDP glucuronosyltransferase family 2 member B4 | 2 | 4 | ||||||||
MIRT506727 | LONRF2 | LON peptidase N-terminal domain and ring finger 2 | 2 | 2 | ||||||||
MIRT523130 | HSP90B1 | heat shock protein 90 beta family member 1 | 2 | 4 | ||||||||
MIRT531338 | TGIF2LX | TGFB induced factor homeobox 2 like, X-linked | 2 | 2 | ||||||||
MIRT534928 | PTPLAD1 | 3-hydroxyacyl-CoA dehydratase 3 | 1 | 1 | ||||||||
MIRT536233 | LRIG3 | leucine rich repeats and immunoglobulin like domains 3 | 2 | 2 | ||||||||
MIRT537092 | GPR135 | G protein-coupled receptor 135 | 2 | 2 | ||||||||
MIRT548286 | FAM3C | family with sequence similarity 3 member C | 2 | 4 | ||||||||
MIRT549143 | BRWD1 | bromodomain and WD repeat domain containing 1 | 2 | 2 | ||||||||
MIRT556354 | MAFK | MAF bZIP transcription factor K | 2 | 2 | ||||||||
MIRT557839 | FKBP1A | FK506 binding protein 1A | 2 | 2 | ||||||||
MIRT564080 | NSA2 | NSA2, ribosome biogenesis homolog | 2 | 2 | ||||||||
MIRT566382 | PLEKHA1 | pleckstrin homology domain containing A1 | 2 | 2 | ||||||||
MIRT573110 | ERBB2IP | erbb2 interacting protein | 2 | 2 | ||||||||
MIRT574403 | TFAP2A | transcription factor AP-2 alpha | 2 | 2 | ||||||||
MIRT576063 | Poteg | POTE ankyrin domain family, member G | 2 | 2 | ||||||||
MIRT619449 | TCF20 | transcription factor 20 | 2 | 2 | ||||||||
MIRT632928 | FGF9 | fibroblast growth factor 9 | 2 | 2 | ||||||||
MIRT633216 | ZNF584 | zinc finger protein 584 | 2 | 2 | ||||||||
MIRT633654 | SLC28A1 | solute carrier family 28 member 1 | 2 | 2 | ||||||||
MIRT637198 | KLHL4 | kelch like family member 4 | 2 | 2 | ||||||||
MIRT646480 | SPATS2L | spermatogenesis associated serine rich 2 like | 2 | 2 | ||||||||
MIRT648314 | SCNN1G | sodium channel epithelial 1 gamma subunit | 2 | 2 | ||||||||
MIRT648631 | LEMD2 | LEM domain containing 2 | 2 | 2 | ||||||||
MIRT655902 | NEK9 | NIMA related kinase 9 | 2 | 2 | ||||||||
MIRT667805 | ITIH5 | inter-alpha-trypsin inhibitor heavy chain family member 5 | 2 | 2 | ||||||||
MIRT675464 | NUBPL | nucleotide binding protein like | 2 | 2 | ||||||||
MIRT675974 | FAM126B | family with sequence similarity 126 member B | 2 | 2 | ||||||||
MIRT676145 | ALDOA | aldolase, fructose-bisphosphate A | 2 | 2 | ||||||||
MIRT676895 | GABPB1 | GA binding protein transcription factor beta subunit 1 | 2 | 2 | ||||||||
MIRT677459 | PDLIM3 | PDZ and LIM domain 3 | 2 | 2 | ||||||||
MIRT677533 | TM4SF5 | transmembrane 4 L six family member 5 | 2 | 2 | ||||||||
MIRT677641 | HAUS2 | HAUS augmin like complex subunit 2 | 2 | 2 | ||||||||
MIRT678806 | HRH4 | histamine receptor H4 | 2 | 2 | ||||||||
MIRT679693 | SLC1A5 | solute carrier family 1 member 5 | 2 | 4 | ||||||||
MIRT679707 | RPL24 | ribosomal protein L24 | 2 | 2 | ||||||||
MIRT698822 | STK38 | serine/threonine kinase 38 | 2 | 2 | ||||||||
MIRT701796 | MRPS25 | mitochondrial ribosomal protein S25 | 2 | 2 | ||||||||
MIRT702220 | LONRF3 | LON peptidase N-terminal domain and ring finger 3 | 2 | 2 | ||||||||
MIRT706095 | ENTPD4 | ectonucleoside triphosphate diphosphohydrolase 4 | 2 | 2 | ||||||||
MIRT706502 | MTMR9 | myotubularin related protein 9 | 2 | 2 | ||||||||
MIRT709780 | NINJ1 | ninjurin 1 | 2 | 2 | ||||||||
MIRT713859 | MBNL1 | muscleblind like splicing regulator 1 | 2 | 2 | ||||||||
MIRT715807 | BBS2 | Bardet-Biedl syndrome 2 | 2 | 2 | ||||||||
MIRT724229 | DGKE | diacylglycerol kinase epsilon | 2 | 2 | ||||||||
MIRT731338 | MET | MET proto-oncogene, receptor tyrosine kinase | 1 | 1 | ||||||||
MIRT731849 | HIF1A | hypoxia inducible factor 1 alpha subunit | 3 | 1 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|